Physician profile
Alice Yee
NPI 1194985879
$1,579.52
in general payments reported to CMS, 2019-2025
18 companies · $630 in 2025
The $630 reported for 2025 was more than what 78% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $668 · 2020: $230 · 2021: $17.95 · 2024: $33.57 · 2025: $630.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $664.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $663.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $374.82 | 2019-2025 | Shingrix, Arexvy |
| Novo Nordisk INC | $163.95 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Amgen INC. | $155.12 | 2019-2025 | Evenity |
| Astrazeneca Pharmaceuticals LP | $153.17 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $140.66 | 2019-2020 | |
| Lilly USA, LLC | $131.68 | 2019-2025 | Zepbound, Mounjaro |
| Bayer Healthcare Pharmaceuticals INC. | $122.25 | 2025 | |
| Pfizer INC. | $80.34 | 2025 | |
| Insmed, INC. | $80.21 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $33.80 | 2019 | |
| Astellas Pharma US INC | $23.75 | 2019 | |
| Exact Sciences Corporation | $22.43 | 2025 | The Cologuard Plus Collection Kit |
| Ibsa Pharma INC. | $20.38 | 2019 | |
| Bavarian Nordic A/S | $19.02 | 2025 | Vivotif |
| Circassia INC. | $17.98 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $13.87 | 2024 | Cabenuva |
| Therapeuticsmd, INC. | $13.21 | 2019 | |
| Sanofi Pasteur INC. | $12.88 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alice Yee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.